Efficacy of salmeterol/fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: analysis from the randomised, placebo-controlled TORCH study

BACKGROUND: The efficacy of inhaled salmeterol plus fluticasone propionate (SFC) in patients with severe or very severe COPD is well documented. However, there are only limited data about the influence of GOLD severity staging on the effectiveness of SFC, particularly in patients with milder disease...

Descripción completa

Detalles Bibliográficos
Autores principales: Jenkins, Christine R, Jones, Paul W, Calverley, Peter MA, Celli, Bartolome, Anderson, Julie A, Ferguson, Gary T, Yates, Julie C, Willits, Lisa R, Vestbo, Jörgen
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2714501/
https://www.ncbi.nlm.nih.gov/pubmed/19566934
http://dx.doi.org/10.1186/1465-9921-10-59

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2714501/
https://www.ncbi.nlm.nih.gov/pubmed/19566934
http://dx.doi.org/10.1186/1465-9921-10-59

Ejemplares similares